Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SAENGenenta Science S.p.A.

Nasdaq · CIK 0001838716
Filer categoryNon-accelerated filer<br>Emerging growth company
Entity typeother
SIC2836 Biological Products, (No Diagnostic Substances)
FY end—
XBRL facts244

Identity from submissions API

NameGenenta Science S.p.A.
CIK0001838716
TickersSAEN, GNTA
ExchangesNasdaq, Nasdaq
Entity typeother
CategoryNon-accelerated filer<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN000000000
LEI—
Fiscal year end—
State of incorporationL6 Italy
Phone39-02-2643-6639
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Genenta Science S.r.l. (2021-03-01T05:00:00.000Z → 2021-05-19T04:00:00.000Z)
Business address
OLGETTINA, NO. 58
MILAN
L6
20132
Italy
Mailing address
OLGETTINA, NO. 58
MILAN
L6
20132
Italy

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

119 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-02 6-K 6-K 0001493152-26-049506 001-41115 261509739 34 43932
2026-10-22 6-K 6-K 0001493152-26-048095 001-41115 261478884 34 23916
2026-10-21 6-K 6-K 0001493152-26-047888 001-41115 261475719 34 32419
2026-10-13 6-K 6-K 0001493152-26-046816 001-41115 261456895 34 25259
2026-10-07 6-K 6-K 0001493152-26-046136 001-41115 261447073 34 20796
2026-10-02 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-045500 005-93511 261435935 34 32103
2026-09-11 6-K 6-K 0001493152-26-042377 001-41115 261374385 34 19072
2026-09-02 6-K 6-K 0001493152-26-041066 001-41115 261351975 34 29246
2026-07-31 6-K 6-K 0001493152-26-035626 001-41115 261228438 34 28014
2026-07-14 6-K 6-K 0001493152-26-033176 001-41115 261174316 34 21845
2026-07-01 6-K 6-K 0001493152-26-031546 001-41115 261145205 34 35936
2026-06-26 6-K 6-K 0001493152-26-030282 001-41115 261129012 34 23730
2026-06-24 6-K 6-K 0001493152-26-029882 001-41115 261113233 34 12886935
2026-06-17 6-K 6-K 0001493152-26-029000 001-41115 261096705 34 588230
2026-06-16 6-K 6-K 0001493152-26-028831 001-41115 261093059 34 18703
2026-05-29 6-K 6-K 0001493152-26-026354 001-41115 261044261 34 284339
2026-05-19 6-K 6-K 0001493152-26-024451 001-41115 261000179 34 55574
2026-05-05 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-021319 005-93511 26944008 34 133087
2026-05-05 4 4 0001493152-26-021237 5822
2026-04-28 6-K 6-K 0001493152-26-019327 001-41115 26907556 34 114924
2026-04-23 6-K 6-K 0001493152-26-018713 001-41115 26888588 34 1227295
2026-04-14 6-K 6-K 0001493152-26-016540 001-41115 26860842 34 18560
2026-04-01 4 4 0001493152-26-014634 5485
2026-04-01 4 4 0001493152-26-014633 5614
2026-04-01 4 4 0001493152-26-014631 5515
2026-04-01 4 4 0001493152-26-014630 5619
2026-04-01 4 4 0001493152-26-014629 5494
2026-04-01 20-F 20-F 0001493152-26-014387 001-41115 26823873 34 14994974 1 1
2026-03-27 6-K 6-K 0001493152-26-013051 001-41115 26800772 34 145744
2026-03-25 3 3 0001493152-26-012690 4809
2026-03-24 6-K 6-K 0001493152-26-012223 001-41115 26783860 34 27738
2026-03-18 3 3 0001493152-26-011257 7997
2026-03-18 3 3 0001493152-26-011210 4646
2026-03-18 3 3 0001493152-26-011208 6836
2026-03-18 3 3 0001493152-26-011206 8126
2026-03-18 3 3 0001493152-26-011205 11676
2026-01-27 424B5 424B5 0001493152-26-003684 333-271901 26561986 33 37380
2026-01-27 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-003681 005-93511 26561984 34 6188
2026-01-27 6-K 6-K 0001493152-26-003675 001-41115 26561980 34 728530
2026-01-27 6-K 6-K 0001493152-26-003673 001-41115 26561976 34 99707
2025-11-04 6-K 6-K 0001493152-25-020653 001-41115 251445684 34 142858
2025-10-28 424B5 424B5 0001493152-25-019853 333-271901 251422828 33 397136
2025-10-28 6-K 6-K 0001493152-25-019808 001-41115 251421199 34 349586
2025-10-27 6-K 6-K 0001493152-25-019384 001-41115 251417334 34 22334
2025-10-10 6-K 6-K 0001493152-25-017756 001-41115 251388160 34 8669746 1 1
2025-10-03 6-K 6-K 0001493152-25-016847 001-41115 251373745 34 18742
2025-09-10 6-K 6-K 0001493152-25-012987 001-41115 251305912 34 45818
2025-08-01 6-K 6-K 0001493152-25-011539 001-41115 251176307 34 19368
2025-03-28 424B5 form424b5.htm 0001641172-25-001211 333-271901 25786845 33 28401
2025-03-28 20-F form20-f.htm 0001641172-25-001207 001-41115 25786732 34 17417872 1 1
2025-03-19 6-K form6-k.htm 0001493152-25-010883 001-41115 25751023 34 492405
2025-03-19 6-K form6-k.htm 0001493152-25-010882 001-41115 25751020 34 45679
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-005630 005-93511 25605760 34 6063
2024-12-30 6-K form6-k.htm 0001493152-24-052474 001-41115 241589769 34 84914
2024-12-20 6-K form6-k.htm 0001493152-24-051070 001-41115 241568325 34 1804670
2024-12-20 424B5 form424b5.htm 0001493152-24-051048 333-271901 241567934 33 119223
2024-12-13 6-K form6-k.htm 0001493152-24-049991 001-41115 241548344 34 2610354
2024-11-14 6-K form6-k.htm 0001493152-24-045794 001-41115 241461648 34 1020638
2024-10-29 6-K form-6k.htm 0001493152-24-042886 001-41115 241405960 34 7534883 1 1
2024-05-03 6-K form6-k.htm 0001493152-24-017701 001-41115 24912980 34 174971
2024-04-26 6-K form6-k.htm 0001493152-24-016787 001-41115 24885463 34 387899
2024-04-26 424B5 form424b5.htm 0001493152-24-016707 333-271901 24884955 33 586071
2024-04-08 6-K form6-k.htm 0001493152-24-013871 001-41115 24830178 34 14591
2024-04-02 6-K form6-k.htm 0001493152-24-012851 001-41115 24815518 34 48895
2024-04-01 20-F/A form20-fa.htm 0001493152-24-012534 001-41115 24811213 34 474068 1 1
2024-03-29 S-8 forms-8.htm 0001493152-24-012005 333-278392 24804568 33 212156
2024-03-29 20-F form20-f.htm 0001493152-24-011999 001-41115 24804514 34 13756868 1 1
2024-02-12 SC 13G/A formsc13ga.htm 0001493152-24-005893 005-93511 24619875 34 68118
2023-10-20 6-K form6-k.htm 0001493152-23-037845 001-41115 231337329 34 16891109 1 1
2023-06-14 6-K form6-k.htm 0001493152-23-021228 001-41115 231014118 34 18723
2023-05-24 EFFECT xslEFFECTX01/primary_doc.xml F-3,,2023-05-24 16:30:00 9999999995-23-001524 333-271901 23955803 33 1748
2023-05-22 CORRESP filename1.htm 0001493152-23-018531 16221
2023-05-22 UPLOAD filename1.pdf 0000000000-23-005404 40239
2023-05-12 F-3 formf-3.htm 0001493152-23-016736 333-271901 23916987 33 1103939
2023-05-10 6-K form6-k.htm 0001493152-23-016155 001-41115 23906270 34 39970
2023-05-01 6-K form6-k.htm 0001493152-23-014964 001-41115 23873540 34 33573
2023-04-21 20-F form20-f.htm 0001493152-23-013272 001-41115 23837331 34 13864239 1 1
2023-03-10 6-K form6-k.htm 0001493152-23-007262 001-41115 23724388 34 16180
2023-02-10 SC 13G/A formsc13ga.htm 0001493152-23-004183 005-93511 23608414 34 68620
2023-02-01 6-K form6-k.htm 0001493152-23-003331 001-41115 23577943 34 453521
2022-12-22 6-K form6-k.htm 0001493152-22-036299 001-41115 221482074 34 580176
2022-12-15 6-K form6-k.htm 0001493152-22-035561 001-41115 221464818 34 31590
2022-10-25 6-K form6-k.htm 0001493152-22-029546 001-41115 221330317 34 61216
2022-10-25 6-K form6-k.htm 0001493152-22-029462 001-41115 221327040 34 5994819 1 1
2022-10-03 6-K form6-k.htm 0001493152-22-027315 001-41115 221285255 34 524916
2022-06-14 6-K form6-k.htm 0001493152-22-016763 001-41115 221015704 34 17191
2022-05-11 6-K form6-k.htm 0001493152-22-012784 001-41115 22912235 34 28321
2022-05-02 20-F form20-f.htm 0001493152-22-011671 001-41115 22878826 34 15767968 1 1
2022-02-25 SC 13G formsc13-g.htm 0001493152-22-005473 005-93511 22677759 34 55978
2022-02-18 SC 13G formsc13-g.htm 0001493152-22-004970 005-93511 22653417 34 71041
2022-02-14 SC 13G formsc13-g.htm 0001493152-22-004404 005-93511 22629779 34 68670
2021-12-16 SEC STAFF LETTER filename1.pdf 9999999997-21-005995 275403
2021-12-15 424B1 form424b1.htm 0001493152-21-031512 333-261653 211493508 33 5504078
2021-12-15 424B1 form424b1.htm 0001493152-21-031510 333-260923 211493505 33 5504078
2021-12-14 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2021-12-14 17:00:00 9999999995-21-004680 333-260923 211492841 33 1749
2021-12-14 F-1MEF formf-1mef.htm 0001493152-21-031484 333-261653 211492744 33 144129
2021-12-14 CERT 8A_Cert_GNTA.pdf 0001354457-21-001453 001-41115 211489937 34 215968
2021-12-10 CORRESP filename1.htm 0001493152-21-031095 16070
2021-12-10 CORRESP filename1.htm 0001493152-21-031093 15196
2021-12-07 F-1/A formf-1a.htm 0001493152-21-030643 333-260923 211474563 33 5149773
2021-12-03 CORRESP filename1.htm 0001493152-21-030356 133517
2021-12-01 8-A12B form8-a12b.htm 0001493152-21-030192 001-41115 211463017 34 25049
2021-11-24 CORRESP filename1.htm 0001493152-21-029881 40924
2021-11-24 F-1/A formf-1a.htm 0001493152-21-029876 333-260923 211448159 33 33531902
2021-11-12 UPLOAD filename1.pdf 0000000000-21-013756 44407
2021-11-09 F-1 formf-1.htm 0001493152-21-027683 333-260923 211393088 33 31374901
2021-10-29 DRSLTR filename1.htm 0001493152-21-026757 47246
2021-10-29 DRS/A filename1.htm 0001493152-21-026756 377-04327 211364315 33 5717439
2021-10-21 SEC STAFF LETTER filename1.pdf 9999999997-21-005541 276008
2021-10-21 UPLOAD filename1.pdf 0000000000-21-012788 46433
2021-10-04 DRS/A filename1.htm 0001493152-21-024413 377-04327 211300928 33 6506036
2021-06-03 UPLOAD filename1.pdf 0000000000-21-006915 43828
2021-05-19 DRS/A filename1.htm 0001493152-21-025353 377-04327 211322264 33 28401836
2021-05-19 DRSLTR filename1.htm 0001493152-21-012239 111543
2021-05-07 UPLOAD filename1.pdf 0000000000-21-005872 48355
2021-04-22 DRSLTR filename1.htm 0001493152-21-009488 85900
2021-04-22 DRS/A filename1.htm 0001493152-21-009482 377-04327 21845732 33 3934223
2021-03-29 UPLOAD filename1.pdf 0000000000-21-003710 64946
2021-03-01 DRS filename1.htm 0001493152-21-005022 377-04327 21693607 33 3681095

Latest XBRL company facts

One latest value per concept from companyfacts (244 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 23.43M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap AccountsPayableCurrent Accounts Payable, Current EUR 1.04M 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current EUR 151,988 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap AccruedBonusesCurrentAndNoncurrent Accrued Bonuses EUR 25,000 2021-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current EUR 202,389 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities EUR 78,172 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment EUR 126,405 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax EUR 166,511 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap AdditionalPaidInCapital Additional Paid in Capital EUR 37.14M 2021-05-20 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition EUR 8,702 2021-01-01 2021-12-31 2021 FY 20-F 2022-05-02 0001493152-22-011671
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition EUR 232,768 2024-01-01 2024-06-30 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense EUR 937,742 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap Assets Assets EUR 31.89M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap AssetsCurrent Assets, Current EUR 29.98M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure EUR 28.15M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap AssetsNoncurrent Assets, Noncurrent EUR 1.91M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap BilledContractReceivables Billed Contracts Receivable EUR 5,000 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CapitalizedComputerSoftwareGross Capitalized Computer Software, Gross EUR 87,800 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CapitalUnits Capital Units, Value EUR 37,771 2021-04-01 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap Cash Cash EUR 4,000 2024-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value EUR 5.53M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure EUR 5.53M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments EUR 17.70M 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations EUR 5.53M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect EUR -17.58M 2023-01-01 2023-06-30 2023 Q2 6-K 2023-10-20 0001493152-23-037845
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations EUR 945,923 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 14.375 2022-12-31 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 2.30M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share EUR/shares 0 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 59.70M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 23.43M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 23.43M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 720,114 2021-12-15 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions EUR 720,114 2021-12-15 2021 FY 20-F 2022-05-02 0001493152-22-011671
us-gaap CommonStockValue Common Stock, Value, Issued EUR 84.26M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent EUR -6.45M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ContractualObligation Contractual Obligation EUR 34,555 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ContractualObligationDueInFourthAndFifthYear Contractual Obligation, to be Paid, Year Four and Five EUR 17,000 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 15.00M 2021-05-19 2021-05-20 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent EUR 7.60M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) EUR 70,360 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 3 2021-05-19 2021-05-20 2021 FY 20-F 2022-05-02 0001493152-22-011671
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure EUR 7.60M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.06 2025-06-04 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs EUR 2.42M 2023-01-01 2023-06-30 2023 Q2 6-K 2023-10-20 0001493152-23-037845
us-gaap DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax EUR 103,439 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss EUR 22.52M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterest DebtSecuritiesAvailableForSaleExcludingAccruedInterest EUR 22.62M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) EUR 26,000 2025-01-01 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap DeferredOfferingCosts Deferred Offering Costs EUR 1.10M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross EUR 16.57M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards EUR 16.08M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other EUR 4,558 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research EUR 2.20M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance EUR 16.57M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net EUR 3,266 2021-12-31 2021 FY 20-F 2022-05-02 0001493152-22-011671
us-gaap DefinedBenefitPlanSpecialTerminationBenefits Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits EUR 88,962 2022-01-01 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.07 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap Depreciation Depreciation EUR 13,941 2025-01-01 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization EUR 28,082 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DisposalGroupIncludingDiscontinuedOperationIntangibleAssets Disposal Group, Including Discontinued Operation, Intangible Assets EUR 0 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap DueFromBanks Due from Banks EUR 3.84M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap DueFromRelatedParties Due from Related Parties EUR 41,149 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap EarningsPerShareBasic Earnings Per Share, Basic EUR/shares -0.2 2025-01-01 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted EUR/shares -0.33 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.1 2023-01-01 2023-06-30 2023 Q2 6-K 2023-10-20 0001493152-23-037845
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations EUR 70,360 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation EUR 197,500 2022-01-01 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current EUR 71,996 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount EUR 2.27M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 1 2020-12-31 2021 FY 20-F 2022-05-02 0001493152-22-011671
us-gaap EquityMethodInvestments Equity Method Investments EUR 37,056 2021-01-01 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap FinanceLeaseLiability Finance Lease, Liability EUR 27,985 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current EUR 12,330 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent EUR 32,407 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due EUR 11,000 2024-06-30 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments EUR 13,967 2025-01-01 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization EUR 7,981 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization EUR 4,583 2022-01-01 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax EUR 1.80M 2022-01-01 2022-06-30 2023 Q2 6-K 2023-10-20 0001493152-23-037845
us-gaap ForeignCurrencyTransactionGainLossAfterTax ForeignCurrencyTransactionGainLossAfterTax EUR 200,000 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-28 0001641172-25-001207
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax EUR -32,011 2022-01-01 2022-12-31 2024 FY 20-F 2025-03-28 0001641172-25-001207
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized EUR 1.60M 2022-01-01 2022-12-31 2024 FY 20-F 2025-03-28 0001641172-25-001207
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized EUR -546,051 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax EUR 200,000 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-28 0001641172-25-001207
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross EUR 15,604 2024-12-31 2024 FY 20-F 2025-03-28 0001641172-25-001207
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense EUR 3.90M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap GeneralInsuranceExpense General Insurance Expense EUR 25,653 2022-01-01 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) EUR 0 2022-01-01 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest EUR -6.53M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount EUR 2.08M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount EUR 126,200 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount EUR -2.33M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount EUR 8,743 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount EUR 3.00M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable EUR 1.19M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities EUR -121,189 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities EUR -218,764 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets EUR 1.58M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities EUR -1,158 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets EUR 17,136 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) EUR 87,000 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross EUR 300,000 2024-06-30 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap InventoryRawMaterialsAndSupplies Inventory, Raw Materials and Supplies, Gross EUR 1.50M 2023-02-28 2023 Q2 6-K 2023-10-20 0001493152-23-037845
us-gaap InvestmentOwnedBalancePrincipalAmount Investment Owned, Balance, Principal Amount EUR 5.42M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap InvestmentOwnedPercentOfNetAssets Investment Owned, Percent of Net Assets pure 0.04 2023-06-30 2023 Q2 6-K 2023-10-20 0001493152-23-037845
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure EUR 10.00M 2023-06-30 2023 Q2 6-K 2023-10-20 0001493152-23-037845
us-gaap LeaseCost Lease, Cost EUR 16,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap LegalFees Legal Fees EUR 8,000 2022-01-01 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap LesseeFinanceLeaseDiscountRate Lessee, Finance Lease, Discount Rate pure 0.063 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.063 2022-02-28 2024 FY 20-F 2025-03-28 0001641172-25-001207
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid EUR 7,575 2024-06-30 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity EUR 31.89M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap LiabilitiesCurrent Liabilities, Current EUR 2.12M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent EUR 7.93M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap LossContingencyAccrualPayments Loss Contingency Accrual, Payments EUR 47.50M 2022-01-01 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross EUR 61,070 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ManufacturingCosts Manufacturing Costs EUR 8.20M 2023-01-01 2023-06-30 2023 Q2 6-K 2023-10-20 0001493152-23-037845
us-gaap MarketableSecurities Marketable Securities EUR 28.10M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current EUR 22.62M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) EUR 9,517 2023-01-01 2023-06-30 2023 Q2 6-K 2023-10-20 0001493152-23-037845
us-gaap MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss EUR 103,439 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) EUR 100,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities EUR 22.29M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities EUR -14.54M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities EUR -6.87M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent EUR -6.53M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap NoncontrollingInterestInNetIncomeLossLimitedPartnershipsNonredeemable Noncontrolling Interest in Net Income (Loss) Limited Partnerships, Nonredeemable EUR 200,000 2023-01-01 2023-12-31 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) EUR 73,913 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap NumberOfOperatingSegments Number of Operating Segments Integer 1 2025-01-01 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses EUR 10.20M 2023-01-01 2023-06-30 2023 Q2 6-K 2023-10-20 0001493152-23-037845
us-gaap OperatingExpenses Operating Expenses EUR 6.60M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap OperatingIncomeLoss Operating Income (Loss) EUR -6.60M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap OperatingLeaseExpense Operating Lease, Expense EUR 13,967 2022-02-01 2022-02-28 2024 FY 20-F 2025-03-28 0001641172-25-001207
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current EUR 13,023 2024-06-30 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent EUR 7,981 2024-06-30 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards EUR 66.86M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap OtherAssetsCurrent Other Assets, Current EUR 209,793 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent EUR 1.60M 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent EUR 70,360 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax EUR 70,400 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax EUR -77,565 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent EUR 77,565 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax EUR -96,234 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax EUR 105,551 2022-01-01 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization EUR 14,000 2025-01-01 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap OtherExpenses Other Expenses EUR 800,000 2022-01-01 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current EUR 119,000 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent EUR 1,158 2024-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) EUR 11,456 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current EUR 190,921 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap PaymentForManagementFee Payment for Management Fee EUR 5.00M 2022-01-01 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap PaymentsForOtherTaxes Payments for Other Taxes EUR 400,000 2024-01-01 2024-06-30 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap PaymentsForRent Payments for Rent EUR 16,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock EUR 172 2021-01-01 2021-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs EUR 68,120 2020-01-01 2020-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets EUR 0 2022-01-01 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities EUR 33.17M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment EUR 7,625 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash EUR 100,018 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent Liability, Defined Benefit Plan, Noncurrent EUR 327,785 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap PostemploymentBenefitsLiabilityNoncurrent Postemployment Benefits Liability, Noncurrent EUR 55,192 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current EUR 1.83M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current EUR 1.83M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap PrepaidInsurance Prepaid Insurance EUR 2,332 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap ProceedsAccountsReceivablePreviouslyWrittenOffRecovery Proceeds, Accounts Receivable, Previously Written Off, Recovery USD 1.32M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt EUR 7.50M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses EUR 50.00M 2021-01-01 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering EUR 28.74M 2021-01-01 2021-12-31 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 100.00M 2023-05-11 2023-05-12 2023 Q2 6-K 2023-10-20 0001493152-23-037845
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity EUR 14.79M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities EUR 18.63M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised EUR 543 2021-01-01 2021-12-31 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap ProductionCosts Production Costs, Period Cost EUR 17,000 2020-10-02 2020-10-31 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization EUR 44,737 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross EUR 148,870 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net EUR 22,465 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) EUR 400,000 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-28 0001641172-25-001207
us-gaap ResearchAndDevelopmentExpense Research and Development Expense EUR 2.70M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) EUR 2.70M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process EUR 197,500 2022-04-27 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) EUR -62.59M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability EUR 49,320 2025-01-01 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability EUR 49,320 2022-02-01 2022-02-28 2024 FY 20-F 2025-03-28 0001641172-25-001207
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold EUR 500,000 2022-01-01 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap SaleOfStockConsiderationReceivedPerTransaction Sale of Stock, Consideration Received Per Transaction EUR 30.00M 2023-05-01 2023-05-31 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap SecuritiesBorrowedFairValueDisclosure Securities Borrowed, Fair Value Disclosure EUR 22.62M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense EUR 1.01M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding EUR 584,132 2020-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested EUR 777,920 2021-01-01 2021-12-31 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 4.36 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.82 2022-01-01 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.023 2022-01-01 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 715 2021-01-01 2021-12-31 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations shares 147,783 2024-04-01 2024-04-30 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 540,523 2022-01-01 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 237,129 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 452,490 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value EUR 57 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 845,607 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price EUR/shares 3.44 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 147,196 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price EUR/shares 3.21 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 1.67M 2025-01-01 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.07M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value EUR 4,643 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.89M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price EUR/shares 2.78 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value EUR 29,878 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 147,783 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price EUR/shares 6.38 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value EUR 4,585 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.05M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price EUR/shares 2.24 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value EUR 937,742 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value EUR/shares 5.3 2024-01-01 2024-06-30 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum pure 0.1 2021-05-01 2021-05-31 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased EUR/shares 1 2022-12-31 2022 FY 20-F 2023-04-21 0001493152-23-013272
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 23,007 2025-06-01 2025-06-30 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award shares 540,523 2022-01-01 2022-12-31 2024 FY 20-F 2025-03-28 0001641172-25-001207
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price EUR/shares 1 2021-01-01 2021-12-31 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price EUR/shares 2.32 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap SharePrice Share Price USD/shares 5.41 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share EUR/shares 300 2021-05-20 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap StockGrantedDuringPeriodValueSharebasedCompensationGross Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture EUR 169 2021-04-01 2021-04-30 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent EUR 21.84M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap StockholdersEquityPeriodIncreaseDecrease Stockholders' Equity, Period Increase (Decrease) EUR 50,000 2024-01-01 2024-12-31 2024 FY 20-F 2025-03-28 0001641172-25-001207
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 2.70M 2021-05-01 2021-05-31 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 856,602 2025-03-20 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units EUR 50,000 2021-05-19 2021-05-20 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 100.00M 2023-05-12 2024 Q2 6-K 2024-10-29 0001493152-24-042886
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues EUR 14.79M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture EUR 1.01M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised EUR 715 2021-01-01 2021-12-31 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase EUR/shares 6.38 2022-01-01 2022-06-30 2022 Q2 6-K 2022-10-25 0001493152-22-029462
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense EUR 937,742 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value EUR 172 2021-01-01 2021-12-31 2023 FY 20-F 2024-03-29 0001493152-24-011999
us-gaap Supplies Prepaid Supplies EUR 16,373 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap TaxesPayableCurrent Taxes Payable, Current EUR 1.10M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ValueAddedTaxReceivable Value Added Tax Receivable EUR 685,630 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ValueAddedTaxReceivableCurrent Value Added Tax Receivable, Current EUR 1.90M 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap ValueAddedTaxReceivableNoncurrent Value Added Tax Receivable, Noncurrent EUR 400,000 2025-06-30 2025 Q2 6-K 2025-10-10 0001493152-25-017756
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 19.71M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 19.71M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-01 0001493152-26-014387

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →